Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation - Wikidata - awgldk - TriplyDB

Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation

Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation

http://www.wikidata.org/entity/Q28582127

about

Mammalian Krüppel-like factors in health and diseases Biology of fibroblasts and myofibroblasts The myofibroblast: one function, multiple origins Endothelial Plasticity: Shifting Phenotypes through Force Feedback The Role of Krüppel-like Factor 4 in Renal Fibrosis Recent developments in myofibroblast biology: paradigms for connective tissue remodeling Myofibroblasts: trust your heart and let fate decide.Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1 Response gene to complement 32 is essential for fibroblast activation in renal fibrosis Ultraconserved elements in the Olig2 promoter.Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3 Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression Krüppel-like factor 4 promotes differentiation by transforming growth factor-beta receptor-mediated Smad and p38 MAPK signaling in vascular smooth muscle cells Visualization and exploration of conserved regulatory modules using ReXSpecies 2 Krüppel-like factor 4 transcriptionally regulates TGF-β1 and contributes to cardiac myofibroblast differentiation.Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition.Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β.Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis.Pharmacological regulation of SPARC by lovastatin in human trabecular meshwork cells.miR-145 regulates myofibroblast differentiation and lung fibrosis.Notch1 signaling in FIZZ1 induction of myofibroblast differentiation Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment.Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA/CREB/CBP signaling in rats with silicosis.Notch in fibrosis and as a target of anti-fibrotic therapy.Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.Chronic alcohol ingestion in rats decreases Krüppel-like factor 4 expression and intracellular zinc in the lung.A novel single-chain Fv antibody for connective tissue growth factor against the differentiation of fibroblast into myofibroblast.Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis.Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-beta.Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase.Muscle fatigue: MK2 signaling and myofibroblast differentiation.BMP signaling orchestrates a transcriptional network to control the fate of mesenchymal stem cells in mice.Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.

P2860

4b676fc8a152eb4981abcde96425740b4330671f

P248

Q24612560-B94D7B7C-958C-4C85-B6FC-B83F68BFCC00 Q24650762-1B06ADCB-2EE3-4EE3-9F94-8DD228C2E0CA Q24683749-BE4643D0-6D3D-4B1B-B0E1-140A4BC9BEE7 Q26767430-C93142D4-C4A6-49D5-8C5B-CCBDF997B48C Q26776165-4765E308-E0EB-4FD6-9FBF-18CAD768AF94 Q26863751-A6A9D61D-2EF8-4598-AE82-A5AC55940038 Q27692541-7B1BADDB-5266-4377-A8F1-70C1FC2D4E9A Q28387716-03DF404B-C890-4D3B-81AB-2F25165F84D7 Q28564646-9034649D-4360-4E1D-8DD2-3A4C6F03929C Q28588339-253274D2-E096-46FE-B92E-798ABAC5C1E1 Q33392711-BF9B357F-E603-491B-895F-90E0094A353A Q33643763-0BFDCF7D-3C8A-4FAB-92CC-3C870ACD2A40 Q33883339-D2FC4CA0-C518-49B6-A848-7272F6BDACBA Q33885311-8670539C-C94F-475B-8D60-82C339182B93 Q34028869-5080BD34-9BF6-4891-9F68-3FA52FAB848C Q34707131-93F94011-EF2C-43DD-8E1C-68D0865771C9 Q34805635-FB07BCB4-943F-415A-9624-82EC935F5EAD Q34979698-BAA37F3C-EABF-4181-9947-049DF047D478 Q35543607-1411C851-4D23-492B-92C0-D4EC35B49D96 Q36044638-A3B03C65-0B0D-40BC-BB7A-44BAEB2A338C Q36103362-DD5E8754-CEFF-497A-9CD8-3B23BB119FFB Q36860296-82FF3A16-6AD8-434E-ADC0-AF3AFD491AB6 Q37164198-B8577761-4988-4397-A30C-8E2AE9E150E7 Q37421300-D95567BF-1FB9-4D33-AA64-64C55A266761 Q37519016-4852DE7C-3BF1-4857-AF77-D4159C65C320 Q37658195-BD68D657-0AE3-4084-96B4-EB364AC3E0E3 Q38815773-0F95A4B2-C787-488A-8A0C-340D409813CE Q38964117-8218F5B7-0ACF-421D-BD1F-64EA9BEF4D10 Q39271100-0BF58880-1E03-4FEA-A493-31B602C499FF Q39429905-BDCB2634-66D4-42B9-A1A4-8D4383CBBA26 Q42396082-DBA65F65-84B4-4BDC-AE45-774011325F1F Q42553529-A239ED75-ED4F-49E7-8954-BE480305A448 Q42743106-85CF21B7-E983-4476-92D1-E5881A002F6F Q43080050-CA609116-9158-490A-BA2F-C4F781C0D779 Q46448138-7FAEFEE1-6237-44B5-B11D-3712F2F087D2 Q47094281-ABB4D962-B9D3-4B3F-A7FD-5F3AB3E8A8A7

P2860

Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation

http://www.wikidata.org/entity/Q28582127

description

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2007

@ast

im Januar 2007 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2007/01/01)

@sk

vědecký článek publikovaný v roce 2007

@cs

wetenschappelijk artikel (gepubliceerd op 2007/01/01)

@nl

наукова стаття, опублікована в січні 2007

@uk

مقالة علمية (نشرت عام 2007)

@ar

name

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@ast

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@en

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@nl

type

label

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@ast

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@en

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@nl

prefLabel

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@ast

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@en

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@nl

P1433

Q28582127-9CC2DD3C-050D-47B2-98BE-63367F970912

P1476

Q28582127-AD3F4973-E10E-485A-A582-E5D4F3ACCA68

P2093

Q28582127-01602642-3413-40CD-8D8A-16BB6B3C2352

Q28582127-0CB7273A-41EC-420F-8603-98DF45339D52

Q28582127-37BAAAA3-FF6C-41C4-A36B-45A899D45279

Q28582127-8C37B7C9-EDDA-4C4E-8076-E76FD9BA3825

Q28582127-D7A53E13-2E15-4E5B-997D-51558F40E435

Q28582127-DE91A9A1-37E3-4E0F-8D73-199A7A5468F4

P2860

Q28582127-00AA6F99-221F-4987-ADAC-35C17F1E9C34

Q28582127-022948D9-8A85-498E-AE19-6928B1370FA1

Q28582127-1252EC4E-2EBD-4E7F-A613-33E13C1A6282

Q28582127-1E897590-9BF2-43A1-8E0D-3DE26307A8B7

Q28582127-478F2AF3-E709-4EC1-AF8B-EB8B5CDB45E5

Q28582127-524988F5-3487-4F69-AECF-3C4E3F44825A

Q28582127-547C3A2B-986B-4E99-BC9C-BB3E8EADAEFA

Q28582127-5B676174-FC84-479B-8AEC-46BD791BF1D8

Q28582127-725B430B-E087-44DE-8EAC-2031BF1852BE

Q28582127-843E3CF0-EDDD-4883-8641-B8ECB02996D5

P304

Q28582127-75A09941-324D-4808-A7A6-2D25272A1C9C

P31

Q28582127-2C23F623-CD9C-4B71-8382-9C11847E60F8

P356

Q28582127-B539A400-41DE-46AA-A45C-24183E4D79D8

P433

Q28582127-5B2F7D20-F7C0-4200-9EEF-07548F0017FF

P478

Q28582127-FA8A33F6-BC5D-4FF8-B974-F162E578C9BF

P577

Q28582127-C57CDFA7-4324-4350-8AF3-F39EECCCA5DC

P698

Q28582127-154576DC-9FDE-4A42-B822-4D8300CC8FA6

P932

Q28582127-1CCBC8EB-D0B2-420E-AB2A-DA8427AC7B69

P356

RCMB.2006-0043OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Gut-enriched Krüppel-like fact ...... myofibroblast differentiation

@en

P2093

Biao Hu

http://www.w3.org/2001/XMLSchema#string

Hong Jin

http://www.w3.org/2001/XMLSchema#string

Matthew R. Ullenbruch

http://www.w3.org/2001/XMLSchema#string

Sem H. Phan

http://www.w3.org/2001/XMLSchema#string

Tianju Liu

http://www.w3.org/2001/XMLSchema#string

Zhe Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest

Receptor-associated Mad homologues synergize as effectors of the TGF-beta response

Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

New insights into TGF-beta-Smad signalling

Human Smad3 and Smad4 are sequence-specific transcription activators

The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3

Smads: transcriptional activators of TGF-beta responses

Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle

Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization

P304

78–84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2006-0043OC

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16858008

http://www.w3.org/2001/XMLSchema#string

P932

1899300

http://www.w3.org/2001/XMLSchema#string